NCT07649148

Brief Summary

Emerging evidence links ultra processed foods (UPFs) to adverse cardiovascular outcomes. UPFs are often high in sodium, unhealthy fats and added sugars, while being low in essential nutrients and fiber. UPFs contribute to systemic inflammation, fluid retention, and metabolic dysfunction-key drivers of HF and kidney disease progression. Traditional dietary counseling often lacks specificity around food processing levels. Furthermore, the majority of nutrition studies relied on extensive self-reported dietary recall food frequency questionnaires (FFQ) that are subjective, often labor intensive, and difficult to implement practically in the clinical setting. As such, researchers have developed metabolite scores from blood and urine samples to help quantify UPF consumption, which has the promise to better guide dietary counseling and track process. Therefore, the aim of this study is to evaluate the feasibility and physiological impact of a structured UPF-reduction dietary intervention in patients with HF, leveraging both digital dietary tools (Cronometer) and biomarker assessments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
168mo left

Started Jun 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Jun 2026Jun 2040

Study Start

First participant enrolled

June 1, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

June 9, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2036

Expected
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2040

Last Updated

June 17, 2026

Status Verified

June 1, 2026

Enrollment Period

10 years

First QC Date

June 9, 2026

Last Update Submit

June 15, 2026

Conditions

Keywords

Diet TrackingDietHeart FailureCronometerUltra Processed Food

Outcome Measures

Primary Outcomes (2)

  • Document Ultraprocessed Food (UPF) Consumption in HF

    To improve understanding of UPF consumption (type(s), amount(s), etc.) in patients with heart failure

    5 years

  • Change in ultraprocessed food (UPF) consumption in heart failure patients

    To investigate the potential for reducing UPF consumption via dietary counseling, Cronometer tracking, and structured patient feedback.

    5 Years

Interventions

Participants in this study will be advised on ways to limit UPF in their diet for a period of 28 days. There is no specific diet to follow. Instead, researchers will ask participants to track what they eat in a mobile app (Cronometer) with the aim of reducing UPF consumption.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults with NYHA Class II-III Heart Failure willing and able to track their diet using a mobile app.

You may qualify if:

  • Adults (≥18 years) with NYHA Class II-III HF
  • Able to use Cronometer to track dietary intake and able to prepare food at home independently (able to modify dietary intake)

You may not qualify if:

  • History of heart transplant or LVAD implant
  • Unable or unwilling to follow dietary coaching for UPF reduction
  • eGFR \<30 ml/kg/1.73m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Main Campus

Cleveland, Ohio, 44195, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood and urine

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • W. H. Wilson Tang, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valesha Province, MS

CONTACT

Jennifer Wilcox

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff, Section of Heart Failure and Cardiac Transplantation Medicine & Staff, Cleveland Clinic Research

Study Record Dates

First Submitted

June 9, 2026

First Posted

June 16, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2036

Study Completion (Estimated)

June 1, 2040

Last Updated

June 17, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Data will only be shared in aggregate and deidentified.

Locations